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What is already known: 
- Bacterial infections are common in patients with cirrhosis  
- Bacterial infections worsen the prognosis of hospitalized patients with cirrhosis 
- The role of infections in changing the natural history of patients with cirrhosis has 
been hypothesized 
 
What is new here: 
- Patients with cirrhosis who become infected have a greater risk of death even if they 
survive the acute episode of infection, independently of the severity of their underlying 
liver disease 
- A single episode of infection was independently associated with survival over and 
above the scores used in transplant centers and degree of liver disease severity 
- Infection most likely represents a distinct prognostic stage of cirrhosis, which affects 
survival irrespective of disease severity 
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Abstract 
Background/aims: We assessed the prognostic significance of infections in relation to 
current prognostic scores and explored if infection could be considered per se a distinct 
clinical stage in the natural history of cirrhosis.  
Methods: We included consecutive patients with cirrhosis admitted to a tertiary referral liver 
unit for at least 48 hours over a 2-year period. Diagnosis of infection was based on positive 
cultures or strict established criteria. We used competing risk analysis and propensity score 
matching for data analysis. 
Results: 501 patients (63% male, 48% alcoholic liver disease, median MELD=17) underwent 
781 admissions over the study period. Portal hypertensive bleeding and complicated ascites 
were the commonest reasons of admission. The incidence of proven bacterial infection was 
25.6% (60% community acquired and 40% nosocomial). Survival rates at 3, 6, 12 and 30 
months were 83%, 77%, 71%, 62% in patients without diagnosis of infection, versus 50%, 
46%, 41% and 34% in patients with diagnosis of infection. Overall survival was 
independently associated with MELD score (HR 1.099), ITU stay  (HR 1.967) and bacterial 
infection (HR 2.226). Bacterial infection was an independent predictor of survival even when 
patients who died within the first 30 days were excluded from the analysis in Cox regression 
(HR 2.013) and competing risk Cox models in all patients (HR 1.46) and propensity risk score-
matched infected and non-infected patients (HR 1.67). 
Conclusions: Infection most likely represents a distinct prognostic stage of cirrhosis, which 
affects survival irrespective of disease severity, even after recovery from the infective 
episode.  
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It is well established that bacterial infections are common in patients with cirrhosis and carry 
a poor prognosis (1). More worryingly, the prevalence of infections by multi-resistant bacteria 
is also increasing (2). Recently, the role of infections in changing the natural history of 
patients with cirrhosis has been hypothesized, and the occurrence of infection in patients with 
cirrhosis has been proposed as a separate clinical stage, based on a meta-analysis of 178 
studies (3). 
Among patients with cirrhosis on the transplant waiting list, prioritization is based on 
predictive scores based primarily on liver disease severity. The relative shortage of organ 
donors renders allocation algorithms of organs essential, and the optimal strategy based on 
scoring systems or waiting time is still under debate. 
The Model for End Stage Liver Disease (MELD) score incorporates serum creatinine, serum 
total bilirubin and INR and is widely used to predict the short-term mortality in patients with 
cirrhosis (4). Many studies have shown its capability to correctly rank potential liver 
recipients according to their severity of liver disease and mortality risk, however, potential 
limitations of this score have been reported (5, 6). Despite their widespread application, the 
prognostic accuracy of all these models is far from being satisfactory and a large number of 
patients still die while on the transplant waiting list, and sometimes with MELD scores below 
the threshold of transplantation. 
D’Amico recently proposed a sub-classification of cirrhosis based on clinical stages with 
distinct one-year mortality that ranges from 1-57% depending on the stage (7). This 
classification is simple and reproducible, defined by clinical criteria that occur in the natural 
history of cirrhosis such as presence of varices, ascites and variceal bleeding and have a 
different prognosis. Infection was proposed as a further stage in this classification (3). 
The aim of this study was twofold, firstly to confirm the prognostic importance of documented 
bacterial infections in patients with cirrhosis and secondly to assess the prognostic 
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significance of infection in relation to current prognostic scores and ascertain if infection 
could be considered per se a distinct clinical stage in the natural history of cirrhosis in a well-
defined cohort of consecutive hospitalized patients. 
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METHODS:  
We evaluated retrospectively all patients with cirrhosis consecutively admitted to the 
Hepatology ward of a tertiary referral liver center over a 2-year period, from 1st January 2007 
to 31st December 2008. Inclusion criteria were diagnosis of cirrhosis based on history, clinical, 
histological, biochemical and imaging features. We excluded patients with a hospital stay of 
less than 48 hours, patients with human immunodeficiency virus (HIV) infection or 
concomitant myeloproliferative disease, patients with HCC outside the Milan criteria and 
those with previous liver transplantation (OLT).  We followed-up patients until OLT or death 
and the latest follow-up data were collected in 31/10/2009 using the national health system-
integrated hospital register. 
The following variables were collected from hospital and laboratory based information 
systems: sex, age and etiology of cirrhosis; severity of liver disease, components of Model of 
End-stage Liver Disease (MELD) and United Kingdom Model for End-stage Liver Disease 
(UKELD). We evaluated blood test results on admission and during hospitalization. Bacterial 
cultures of blood, urine, peritoneal and pleural fluid were performed whenever infection was 
suspected based on clinical and/or laboratory signs, and all positive cultures were recorded. 
Patients with ascites or pleural effusion had a diagnostic tap performed for cell count and 
cultures when appropriate. According to the aetiology of cirrhosis, the patients were classified 
into three groups: viral hepatitis (HBV and HCV), alcohol and all other aetiologies. 
According to international criteria, diagnosis of infection was based on the following: 
Spontaneous bacterial peritonitis or spontaneous empyema (SBP and SE) were defined as a 
neutrophil cell count in ascitic and pleural fluid ≥250/mm3 respectively, or positive culture 
(8). A clean-catch midstream urine specimen for culture and chemical analysis was collected, 
when urinary tract infection (UTI) was suspected, and UTI was diagnosed as follow: a) urine 
leukocyte count ≥10 cells/mm3 and positive urine culture, b) fever, pyuria (≥10 
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leukocytes/mm3) and ≥100,000 CFU/ml, or c) uncountable leukocytes without positive 
culture (9). In patients with documented or suspected pneumonia, bronchial secretions were 
collected as appropriate; in case of negative cultures, pneumonia was diagnosed if there was 
radiological evidence of pulmonary infiltration combined with at least two of the following 
criteria: fever >38°C or hypothermia <35.5°C, dyspnea, cough and purulent sputum, pleural 
chest pain, or signs of consolidation on physical examination. Other body fluids, like bile, and 
swabs were cultured when an infection was clinically suspected and infections were 
diagnosed according to clinical, radiological, and microbiologic data following standard 
criteria (10). Screening swabs for MRSA were not evaluated unless a clinically relevant 
(bloodstream or wound) MRSA infection was diagnosed. Infections were considered 
community acquired (CA) when diagnosed at admission or developed within 48 hours after 
hospitalization and nosocomial when the diagnosis was made thereafter (11). Health-care 
associated (HCA) infections were not defined, as this study was planned before this 
classification was routinely used in Hepatology practice (12, 13). 
 
STATISTICAL ANALYSIS:  
Categorical variables are presented as number and percentage, while quantitative variables 
are summarized by mean and standard deviation (SD) if the distribution is normal or median 
and interquantile range if not.  
The end point was death. The follow-up periods began with first admission and ended with 
death or liver transplantation, censoring the remaining patients at the last follow-up contact 
at the hospital or with their general practitioner. The latter were contacted for such 
information. In the first instance, Cox regression analysis was performed and patients who 
were transplanted were censored as alive at the time of transplantation. We also used 
competing risk Cox regression analysis, with death and liver transplantation considered as 
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competing risks. In order to minimize the probability of selection bias, we repeated the 
analysis in a cohort of infected and non-infected propensity score matched patients.  
Mortality rate/100 person/year was calculated and survival was described with the Kaplan-
Meier method. Uni- and multivariate Cox regression and competing risk Cox regression 
models were fitted to identify the most important predictors of outcome. Variables with p<0.1 
at univariate analysis were checked for collinearity and entered in the multivariate model, 
using a stepwise forward approach. Each patient was considered once in the analysis 
irrespective of the number of hospital admissions. Among patients with more than one 
hospital admissions, the date of first admission was analyzed for patients without infection, 
whereas for patients with infection we considered the admission with the first diagnosis of 
infection. In order to address immortal time bias, additional analyses were performed 
by classifying the infection event as a categorical time-dependent covariate in Cox 
survival models (14). 
We carried out a propensity analysis using logistic regression to create a score for the infected 
and non-infected patients. This model included MELD, hepatocellular carcinoma, patients 
transplanted, reasons of admission (acute decompensation or infection versus others) as well 
as the interaction term with p≤0.10 (MELD×reasons of admission). We used nearest-
neighbour matching method with no replacement to match patients in the non-infected group 
with those in the infected group, with a calliper width of 0.2 of the standard deviation of the 
logit of the propensity score. After matching appropriate non-parametric paired tests were 
used (Wilcoxon signed-rank test for continuous variables and McNemar test for dichotomous 
variables). 
All analyses were performed using SPSS version 22.0 for Windows (IBM, New York, NY, USA), 
except from the competing risk analyses, which were performed using Stata version 12.1 
(Statacorp, College Station, Texas, USA). 
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RESULTS:  
Patients 
Over the study period, 501 patients with cirrhosis were consecutively admitted to our 
hospital for more than 48 hours. Of these, 84 patients underwent OLT (18 in the infected 
group) and were censored as alive at the time of the transplant for the traditional survival 
analysis, while there was no follow-up information beyond admission for 14 (8 in the non-
infected and 6 in the infected group). Patients on the liver-transplant list and patients with 
HCC were equally distributed among infected and non-infected patients. Further admissions 
occurred in 280 patients during the study period (153 patients had 2, 127 patients had 3 or 
more admissions) for a total of 781 different hospital admissions. Mean follow-up was 12.7 
(SD 10.4) months. 
There were 317 males and 184 females, with a mean age of 53.3 (SD 12.3). Most patients had 
severe liver disease (85% MELD>10 and 56% >15, while 80.5% were Child-Pugh score B or 
C); mean admission MELD was 17.1 (SD 6.9) and UKELD was 55.6 (SD 6.4). The aetiology of 
cirrhosis was alcohol in 242 (48.3%), viral (HBV or HCV-related) in 114 (22.8%), and non 
viral-non alcohol in 145 (28.9%) cases, including 32 patients with cryptogenic cirrhosis 
and 15 with NASH. Forty-four patients had HCC and their distribution was even in the 
infected and non-infected groups. Table 1 shows main clinical characteristics and laboratory 
findings at admission of the total cohort, in infected and non-infected patients. The 
characteristics of propensity score matched infected and non-infected patients are shown in 
the Appendix. The mean MELD score of patients with infection at discharge did not 
significantly differ from their MELD score at admission (19.7±9.1 vs. 18.7±7.3, P=0.35) 
and was stable in 35% of the infected patients, improved in 32% and deteriorated in 
33%.  
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Patients were hospitalized on account of decompensation of liver disease in 59.1% of cases, 
particularly for tense ascites (17.6% of cases), active gastrointestinal bleeding (18.6%), 
hepatic encephalopathy (9.4%) or jaundice (13.6%). Presence of overt infection accounted for 
10.4% of the reasons of admission and elective procedures such as TIPS assessment and 
placement, loco-regional therapies for hepatocellular carcinoma (HCC), pre-transplant work-
up or clinical reason not related with decompensation of liver disease for the remaining 
30.5% of cases.   
 
Hospital stay and prevalence of infection 
Median length of in-hospital stay was 10 days (IQR 12.0), with a significant difference 
between infected and non-infected patients (25.1 vs. 10.2 days; p <0.001). 49 patients were 
transferred from the ward to intensive care (ITU) and stayed there for a median of 7 days 
(IQR 10).  
On a total of 781 admissions in 501 different patients, the prevalence of infection was 25.6% 
(n=200). In total, 60% (n=120) of infections were CA  (in 54 cases infection was already overt 
at admission, the remaining developed symptoms within 48 hour) and 40% (n=80) were 
nosocomial infections. There were two patients with bacterascites who were not treated 
with antibiotics and were considered as non-infected patients.  In 52 patients, there were 
no positive cultures and diagnosis was based on a combination of clinical, biochemical and 
radiological criteria: 9 cases of pneumonia, 14 of SBP, 1 of UTI and 27 cases with other sites of 
infections (biliary source, soft tissues). Bacterial isolation was more prevalent in nosocomial 
than CA infections (98.8% versus 57.5%; p <0.001). 
 
Aetiology and predictors of infection 
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Characteristics and factors associated with the presence of infection were evaluated on the 
total of 781 admissions. 148/200 (74.4%) infection cases were culture-positive bacterial 
infections; in some cases, multiple sites or multiple bacteria where isolated in the same 
patients for a total of 259 positive cultures. The majority of positive cultures involved gram-
positive cocci (58.1%). The most common sites of bacterial isolation were blood, ascitic fluid 
and urine with 73 (28.2%), 71 (27.4%) and 37 (14.3%) positive cultures respectively. 
Prevalence of multi-resistant strains was 23.1%, and there was no difference among 
community-acquired and hospital-acquired infections (20.2% (n=24) vs. 27.5% (n=22); P 
0.236). Methicillin-resistant Staphylococcus Aureus, MRSA (n=22), was the most frequently 
isolated multi-resistant strain, followed by Extended Spectrum β-Lactamase, ESBL (N = 20), 
gram negative multiresistant bacteria such as Pseudomonas aeruginosa, citrobacter freundii, 
serratia marcescens and stenotrophomonas maltophilia (n =5), acinetobacter baumanni (n = 
3) and vancomycin resistant enterococcus (n = 2). A summary of the principal characteristics 
of infections and cultures is presented in Table 2. 
Factors associated with infection are presented in the Appendix. 
 
Outcomes 
Analysis of outcomes was conducted considering only one admission per patient, either the 
first or the one with a diagnosis of infection. 
190 patients died from the date of first admission, of which 52 died in-hospital, in a mean 
follow-up of 12.7 (SD 10.4) months. 
In-hospital mortality rate was higher in those patients who presented with infection and/or 
developed infection during hospitalization (HR 5.02; 95%CI: 2.75-9.16; p<0.001). Also, 
mortality was higher in this group even for patients who were discharged from hospital (HR 
1.59; 95%CI: 1.12-2.25; p 0.009) and it remained so after excluding early deaths (n=44), i.e. 
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deaths that occurred less than 30 days from admission (HR 1.78; 95%CI: 1.28-2.49; p = 
0.001).  
Variables which were significantly associated with both 30 days (see appendix) and overall 
mortality (see table 3) according to univariate analyses were diagnosis of infection, reason of 
admission acute decompensation of liver disease or infection, more severe disease (UKELD, 
MELD and Child-Pugh score non-A), ITU stay, advanced age and longer hospital admissions.  
Mean survival of patients who were diagnosed with infection during hospitalization was 16.8 
months, compared to 25.5 months of patients who didn’t have an infection (HR 2.14; 95%CI: 
1.61-2.85; P<0.001). There was no significant difference between mortality in patients with 
resistant bacteria infections (n=24/34) compared with non-resistant infections (n=63/126), 
with a mean survival of 12.2 vs. 18.1 months respectively (HR: 1.53; 95%CI: 0.95-2.44; p 
0.077). Furthermore, no difference in survival between patients with CA and HA infections 
was seen (p = 0.48). 
Variables significant at univariate analysis were entered into logistic regression models to 
assess their relationship with the end-point. As before, due to co-linearity UKELD and reason 
of admission were not included in the model. Of the 118 patients who were admitted for 
reasons other than acute decompensation or infection, 21 developed an infection. 
Infection was significantly associated with overall mortality in this subgroup (HR 
1.381, 95%CI 1.178-1.618). Variables independently associated with higher 30-day 
mortality rate were the presence of infection at admission and/or during hospitalization (OR 
2.91; 95%CI: 1.48-5.70; p 0.002), MELD score (OR 1.11; 95%CI: 1.07-1.15; p < 0.0001), ITU 
stay (OR 2.76; 95%CI: 1.42-5.34; p 0.003) and repeated admissions (OR 2.27; 95%CI: 0.99-
5.24; p 0.054) (see Appendix). 
 Variables independently associated with higher overall mortality rate were the diagnosis of 
bacterial infection (HR 1.79; 95%CI: 1.33-2.41; p < 0.001), MELD score (HR 1.09; 95%CI: 1.07-
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1.11; p < 0.001), ITU stay (HR 1.67; 95%CI: 1.10-2.53; p 0.017) and age (HR 1.03; 95%CI: 
1.02-1.04; p < 0.001). All the above is summarized in Table 3. The same predictors of 
mortality were significant when competing risk analysis was used in the whole cohort (Table 
3), in propensity score matched infected and non-infected patients (Table 4) and when 
immortal time bias was taken into account for patients who developed an infection 
after their first admission (Appendix).  
When multivariate analysis was repeated excluding early deaths i.e. only including patients 
who survived at least 30 days after the episode of infection, MELD, history of infection and age 
were independent predictors of mortality  (Table 5). Predictors of survival did not change 
when competing risk analysis was performed in the whole cohort (Table 5), in propensity 
score matched infected and non-infected patients (Appendix) and when immortal time bias 
was taken into account for patients who developed an infection after their first 
admission (Appendix).  
Survival rates at 3, 6, 12 and 30 months were 83%, 75%, 68%, 59% in patients without 
diagnosis of infection, versus 55%, 51%, 45% and 39% in patients with diagnosis of infection. 
Survival rate at 3, 6, 12 and 30 months was 92%, 87%, 79% and 66% in those with MELD <15 
and 67%, 61%, 57%, 45% in those with MELD ≥15.   
Survival was worse in patients with bacteremia/SBP/pneumonia (14.2 months) 
compared to patients with other infections (20.8 months). 
Figures show the Kaplan Meier survival curves in patients with and without diagnosis of 
infection (Fig. 1) and stratified by MELD < or ≥15 and diagnosis of infection (Fig. 2).  
In all stages of disease, mean survival was significantly lower in infected versus non-infected 
patients (log rank test for all analyses). In particular in patients with MELD <15, mean 
survival was 19.0 (15.3-22.8) vs. 27.1 (25.1-29.1) months, in those with and without infection 
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respectively. Likewise, in patients with MELD ≥15, mean survival was 14.9 (11.6-18.1) 
months vs. 20.9 (18.5-23.2) in those with and without infection respectively (P<0.001).  
Results were similar across all Child-Pugh classes: In 88 patients with Child-Pugh A, mean 
survival was 22.3 (15.4-29.2) vs. 27.1 (24.5-29.7) months in those with and without infection 
respectively (P=0.165), with no deaths occurring within the first month after the infective 
episode. In 213 patients with Child-Pugh class B mean survival was 19.6 (15.7-23.5) vs. 25.5 
(23.3-27.7) months in patients with and without infection, respectively (P = 0.002), while in 
158 patients with Child-Pugh class C mean survival in these groups was 12.2 (8.5-15.9) 
vs.17.2 (13.8-20.6) months (P = 0.023). 
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DISCUSSION 
 
In this study, we have shown for the first time that patients with cirrhosis who become 
infected have a greater risk of death even if they survive the acute episode of infection, 
independently of the severity of their underlying liver disease. We have further provided 
updated data on the prevalence and microbiology of bacterial infections in this setting.  
We have included consecutive patients over a 2-year period and have followed them up for a 
median time of over 1 year. We have employed strict criteria to define bacterial infection in 
order to obtain robust data on the influence of infection. Our findings are striking in the sense 
that a single episode of infection was independently associated with survival over and above 
the scores used in transplant centers and degree of liver disease severity. Indeed, the 
occurrence of bacterial infection for a similar MELD score confers a very different prognosis, 
and in all stages of disease survival was significantly lower in infected patients than non-
infected. Importantly patients with MELD scores <15 and infection, have a mortality rate very 
similar to those with MELD score ≥15 and no infection. Even when patients who did not 
survive the acute episode of infection were censored, an anamnestic history of infection still 
represented an independent predictor of survival. 
These results obtained in a strictly defined cohort of patients confirm the previous findings of 
our meta-analysis of 178 studies showing that infections increase mortality in cirrhosis 4-fold, 
with 30% of patients dying within one month after infection and 30% dying within one year 
(3). This meta-analysis included cohorts with different definitions of infection and varying 
disease severity, therefore important questions were left unanswered. Most importantly, we 
could not ascertain if patients with cirrhosis who get infected have a greater risk of death, or if 
patients with cirrhosis at risk of death get infections in the process of dying. Data from this 
study point towards the first answer and suggest that infection alters the natural history of 
cirrhosis and confers a higher risk of death. This effect is independent of the Child-Pugh or the 
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MELD score and was recently described in a cohort of patients with compensated cirrhosis 
due to viral hepatitis (15). Therefore, infection should be regarded as a separate stage of 
cirrhosis and possibly be added to the list of decompensating events, similar to ascites and 
variceal bleeding as was previously suggested (3, 16, 17). 
The cause of a high prevalence of infections in patients with cirrhosis is double: firstly 
patients with advanced chronic liver disease have severe disturbances in the defense 
mechanisms against bacterial infections (a depressed function of the reticuloendothelial 
system, neutrophil dysfunction, reduced serum complement and low bactericidal opsonin 
activity, monocyte deactivation) (18). Secondly, bacterial translocation from the intestine 
increases susceptibility to infection and becomes clinically significant when it results in 
spontaneous bacterial peritonitis (SBP) and/or bacteraemia. Infection may lead to a systemic 
inflammatory response syndrome and sepsis, further deteriorating the circulatory 
disturbance in cirrhosis, and increasing the risk to develop renal failure, encephalopathy and 
death. Infection, even after the resolution of an acute episode, may maintain increased levels 
of endotoxins, bile acids, nitric oxide, carbon monoxide, and cytokines such as tumor necrosis 
factor and interleukin-6 (1, 19). Indeed, the levels of these pro-inflammatory mediators may 
not return to baseline after resolution of the actual infection thus promoting a cascade of 
events that culminates in liver failure. Alternative or additional reasons have been proposed 
to explain the high mortality consequent to bacterial infections in cirrhosis, such as a 
cytokine-mediated septic cardiomyopathy (20) and the adrenal dysfunction that accompany 
the liver disease (21). It is also possible that an anamnestic infective episode further worsens 
or induces immune-paresis and macrophage and neutrophil dysfunction, thus worsening 
survival (22). 
In this study we confirmed the high prevalence of infections (26.2%) in hospitalized patients 
with cirrhosis as reported by other studies (2, 12, 23-25), and also that bacterial infections 
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worsen the prognosis of hospitalized patients with cirrhosis thus increasing mortality. We 
have also provided data beyond 30-day mortality that has been usually provided in such 
studies (23, 26). It should be noted that the prevalence of infections has not decreased over 
the past 15 years, despite a more advanced knowledge of the responsible mechanisms and the 
possibility for an early diagnosis. On the contrary, infections caused by multidrug resistant 
bacteria (MDRB) are increasing, and can lead to worse outcome (2). Indeed, the prevalence of 
this type of infection was over 20% in our cohort; although we did not show a statistically 
difference in mortality between MDRB and non-MDRB infections, this is probably due to a 
type I error as the mean survival difference was 5 months in these groups. 
These findings have important clinical implications. For patients on the transplant-waiting 
list, organ allocation systems using minimal listing criteria may disadvantage patients with 
recent bacterial infections but lower MELD or UKELD scores. Indeed, although such scores 
allow for the allocation of organs to patients in greatest need, as they are reliable measures of 
mortality risk in patients with end-stage liver disease, they do not take into account a history 
of complications including infection and may not accurately reflect the adverse impact of 
bacterial infection on survival in patients with cirrhosis.  
In accord with the hypothesis that occurrence of bacterial infection represents a further 
prognostic stage, our study confirms that mortality in a large population of patients with 
cirrhosis is strongly increased by any type of bacterial infection, regardless of the severity of 
liver disease. The development of infection therefore is independent of the clinical 
classification of cirrhosis and likely depends on individual factors, such as genetic 
predisposition, intestinal permeability, bacterial translocation and immune activation. Along 
these lines, the development of biomarkers of susceptibility to infection will help to identify 
patients at risk and intervene at an earlier stage. Indeed, an earlier recognition and treatment 
of infection may be of great value to reduce mortality in these patients. Furthermore, new 
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studies of primary and secondary prevention of infections beyond SBP are needed to improve 
outcomes, similar to the seminal ones for SBP (18). 
The main limitation of this study is its retrospective design, although we did include 
consecutive patients and we were able to obtain all required data from the patients’ notes 
based on a predetermined protocol. Furthermore, we performed a sub-analysis on propensity 
score matched infected and non-infected patients. Our study cohort cosists of patients 
hospitalized in 2007-2008, therefore is not contemporary. However, there have been 
no major changes in the standard of care of decompensated patients since then and the 
magnitude of the effect of infections in survival is such that the results are pertinent for 
contemporary cohorts. We could not analyze separately patients that fulfilled the criteria for 
acute-on-chronic liver failure, as this term had not been introduced when this study was 
designed and data were captured (27). Finally, we didn’t consider the category of HCA 
infections, which was only recently introduced in hepatology practice (12). 
In conclusion, we demonstrated that infection most likely represents a distinct prognostic 
stage of cirrhosis, which affects survival irrespective of disease severity. Our findings suggest 
that the occurrence of infection, even with recovery, should be regarded as a prognostic stage 
of cirrhosis beyond the decompensated stages and the term critically ill cirrhotic could be 
used for such patients. Future prospective studies should be directed at verifying the 
importance of this stage and evaluating parameters allowing the identification of infected 
patients with an increased risk of worse outcome in the short-term. From a more therapeutic 
point of view, studies addressing the primary and secondary prevention of infections other 
than SBP are needed to improve outcomes or to facilitate a smoother management towards 
liver transplantation. 
 
  
Page 19 of 42
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901
American Journal of Gastroenterology
For Peer Review
References 
1. Jalan R, Fernandez J, Wiest R, et al. Bacterial infections in cirrhosis: a position 
statement based on the EASL Special Conference 2013. J Hepatol 2014;60:1310-24. 
2. Fernandez J, Acevedo J, Castro M, et al. Prevalence and risk factors of infections by 
multiresistant bacteria in cirrhosis: a prospective study. Hepatology 2012;55:1551-61. 
3. Arvaniti V, D'Amico G, Fede G, et al. Infections in patients with cirrhosis increase 
mortality four-fold and should be used in determining prognosis. Gastroenterology 
2010;139:1246-56, 1256 e1-5. 
4. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with 
end-stage liver disease. Hepatology 2001;33:464-70. 
5. Cholongitas E, Marelli L, Kerry A, et al. Female liver transplant recipients with the same 
GFR as male recipients have lower MELD scores--a systematic bias. Am J Transplant 
2007;7:685-92. 
6. Tripodi A, Chantarangkul V, Primignani M, et al. The international normalized ratio 
calibrated for cirrhosis (INR(liver)) normalizes prothrombin time results for model for end-
stage liver disease calculation. Hepatology 2007;46:520-7. 
7. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of 
survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006;44:217-31. 
8. Rimola A, Garcia-Tsao G, Navasa M, et al. Diagnosis, treatment and prophylaxis of 
spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol 
2000;32:142-53. 
9. Sobel JD, Kaye D. Urinary tract infections. In: Mandell GL, Bennet JE, Dolin R, editors. 
Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone; 1995. 
p. 662-690. 
Page 20 of 42
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901
American Journal of Gastroenterology
For Peer Review
10. Fasolato S, Angeli P, Dallagnese L, et al. Renal failure and bacterial infections in 
patients with cirrhosis: epidemiology and clinical features. Hepatology 2007;45:223-9. 
11. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections, 1988. 
Am J Infect Control 1988;16:128-40. 
12. Merli M, Lucidi C, Giannelli V, et al. Cirrhotic patients are at risk for health care-
associated bacterial infections. Clin Gastroenterol Hepatol 2010;8:979-85. 
13. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-
associated infection and criteria for specific types of infections in the acute care setting. Am J 
Infect Control 2008;36:309-32. 
14. Giobbie-Hurder A, Gelber RD, Regan MM. Challenges of guarantee-time bias. J Clin 
Oncol 2013;31:2963-9. 
15. Nahon P, Lescat M, Layese R, et al. Bacterial infection in compensated viral cirrhosis 
impairs 5-year survival (ANRS CO12 CirVir prospective cohort). Gut 2015. 
16. Fede G, D'Amico G, Arvaniti V, et al. Renal failure and cirrhosis: a systematic review of 
mortality and prognosis. J Hepatol 2012;56:810-8. 
17. Tsochatzis EA, Bosch J, Burroughs AK. New therapeutic paradigm for patients with 
cirrhosis. Hepatology 2012;56:1983-92. 
18. Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet 2014;383:1749-61. 
19. Navasa M, Follo A, Filella X, et al. Tumor necrosis factor and interleukin-6 in 
spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal 
impairment and mortality. Hepatology 1998;27:1227-32. 
20. Alqahtani SA, Fouad TR, Lee SS. Cirrhotic cardiomyopathy. Semin Liver Dis 
2008;28:59-69. 
21. Fede G, Spadaro L, Tomaselli T, et al. Adrenocortical dysfunction in liver disease: a 
systematic review. Hepatology 2012;55:1282-91. 
Page 21 of 42
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901
American Journal of Gastroenterology
For Peer Review
22. Tritto G, Bechlis Z, Stadlbauer V, et al. Evidence of neutrophil functional defect despite 
inflammation in stable cirrhosis. J Hepatol 2011;55:574-581. 
23. Bartoletti M, Giannella M, Caraceni P, et al. Epidemiology and outcomes of bloodstream 
infection in patients with cirrhosis. J Hepatol 2014;61:51-8. 
24. Borzio M, Salerno F, Piantoni L, et al. Bacterial infection in patients with advanced 
cirrhosis: a multicentre prospective study. Dig Liver Dis 2001;33:41-48. 
25. Bajaj JS, O'Leary JG, Reddy KR, et al. Second infections independently increase 
mortality in hospitalized patients with cirrhosis: the North American consortium for the study 
of end-stage liver disease (NACSELD) experience. Hepatology 2012;56:2328-35. 
26. Cazzaniga M, Dionigi E, Gobbo G, et al. The systemic inflammatory response syndrome 
in cirrhotic patients: relationship with their in-hospital outcome. J Hepatol 2009;51:475-82. 
27. Moreau R, Jalan R, Gines P, et al. Acute-on-Chronic Liver Failure Is a Distinct Syndrome 
That Develops in Patients With Acute Decompensation of Cirrhosis. Gastroenterology 
2013;144:1426-1437. 
Page 22 of 42
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901
American Journal of Gastroenterology
For Peer Review
Table 1. Demographic and clinical characteristics of included patients (n=501). 
Variable 
All patients 
(n=501) 
Non-infected 
(n=335) 
Infected 
(n=166) 
P 
Age, years (SD) 53.3±12.3 53.1±12.2 53.8±12.7 0.52 
Male gender, n (%) 317 (63.3) 217 (64.8)  100 (60.2) 0.32 
Etiology    0.19 
Alcohol, n (%) 242 (48.3) 155 (46.3) 87 (52.4)  
Viral (HBV and/or HCV), n (%) 114 (22.8) 84 (25.1) 30 (18.1)  
Other, n (%) 145 (28.9) 96 (28.7) 49 (29.5)  
Clinical scores     
Child-Pugh class, n (%)    <0.001 
A 92 (18.4) 75 (23.8) 17 (10.9)  
B 219 (46.5) 152 (48.3) 67 (42.9)  
C 160 (34.0) 88 (27.9) 72 (46.2)  
MELD score  17.1±6.9 16.3±6.7 18.7±7.0 <0.001 
UKELD score (SD) 55.6±6.8 54.6±6.5 57.8 ±7.0 <0.001 
HCC, n (%) 44 (8.8) 34 (10.1) 10 (6) 0.135 
Laboratory data     
WBC, * 103/ml (IQR) 6.8 (5.1) 6.4 (4.8) 7.7 (5.9) 0.022 
Serum creatinine, mg/dl (IQR) 0.8 (0.4) 0.8 (0.4) 0.8 (0.5) 0.026 
Serum bilirubin, mg/dl (IQR) 2.6 (5.4) 2.4 (5.0) 3.5 (7.9) 0.147 
INR (SD) 1.5±0.69 1.6±0.7 1.7±0.6 0.132 
C-reactive protein, mg/dl (IQR) 14 (32) 9 (20) 26.5 (44.8) <0.001 
Albumin, g/dl (SD) 3.1±0.7 3.3±0.7 2.9±0.6 <0.001 
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Na, mEq/L (SD) 136±6.1 137±5.5 134±6.9 <0.001 
Haemoglobin, g/dl (SD) 11.3±2.4 11.5±2.4 10.9±2.1 0.006 
Platelets, *106/ml (IQR) 121 (115) 118 (121) 126 (102) 0.59 
 
*Continuous data are expresses as mean±SD or median (IQR) according to distribution 
normal or not normal respectively. 
Abbreviations: SD, standard deviation; IQR, interquartile range; HBV, hepatitis B virus; HCV, 
hepatitis C virus; MELD, model for end stage liver disease; UKELD, United Kingdom end stage 
liver disease; WBC, white blood cell; INR, international normalized ratio 
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Table 2. Characteristics of cases of infection and cultures among all 781 admissions 
Cases of infection, N (%) 200 (25.6) 
Infections with ≥1 positive culture 148 (74) 
Nosocomial 80 (40) 
Polymicrobial infections 59 (29.5) 
Isolation of MDR bacteria 46 (23.1) 
Gram-negative 100 (41.8) 
Gram-positive 139 (58.2) 
Sites of bacterial isolation  
Bacteremia 73 (28.2) 
Ascites 71 (27.4) 
Pleural fluid 9 (3.5) 
Urine 37 (14.3) 
Other sites (skin infection, biliary 
source or no identifiable source) 
69 (26.6) 
 
Abbreviations: MDR, multidrug-resistant; UTI, urinary-tract infections; SBP, spontaneous 
bacterial peritonitis. 
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Table 3. Survival analysis: factors predictive of overall mortality 
 
 
Univariate Cox regression 
analysis 
Multivariate Cox regression 
analysis 
Multivariate Cox regression 
Competing risks: 
Death or LT 
 HR 95% CI P HR 95% CI P HR 95% CI P 
MELD score 1.087 1.066-1.108 <0.001 1.090 1.067-1.114 <0.001 1.09 1.07-1.12 <0.001 
Presence of bacterial infection 2.141 1.608-2.850 <0.001 1.793 1.333-2.413 <0.001 1.77 1.29-2.43 <0.001 
ITU stay 2.046 1.361-3.077 0.001 1.665 1.097-2.527 0.017 2.14 1.34-3.44 0.002 
UKELD score 1.086 1.064-1.108 <0.001       
CPS B and C 2.275 1.443-3.588 <0.001       
In-hospital stay >10 days 1.799 1.337-2.421 <0.001       
Admission for decompensated 
liver disease or infection 
1.531 1.093-2.144 0.013    
   
Age 1.02 1.01-1.03 0.001    1.03 1.02-1.05 <0.001 
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Table 4. Competing risk Cox regression analysis of variables associated with death in total cohort, in propensity score-matched patients  
(competing risks are death and liver transplantation). 
 Univariate analysis  
Multivariate analysis 
Competing risks: Death or LT 
 
 HR se(HR) 95% CI P HR se(HR) 95% CI P 
MELD score 1.07 0.02 1.04-1.10 <0.001 1.09 0.02 1.06-1.13 <0.001 
History of bacterial infection 
(yes) 
1.75 0.29 1.26-2.43 0.001 1.65 0.31 1.15-2.39 0.007 
ITU stay (yes) 2.18 0.56 1.32-3.60 0.002 2.19 0.57 1.32-3.64 0.003 
UKELD score 1.07 0.02 1.04-1.10 <0.001 - - - - 
CPS B and C 1.60 0.45 0.92-2.79 0.10 - - - - 
In-hospital stay >10 days 1.56 0.27 1.11-2.19 0.01 - - - - 
Admission for decompensated 
liver disease or infection (yes) 
1.12 0.26 0.71-1.75 0.63 - - - - 
Age 1.02 0.01 1.01-1.04 <0.001 1.04 0.01 1.02-1.05 <0.001 
Admissions (≥2) 1.11 0.19 0.80-1.54 0.60 - - - - 
 
Abbreviations: ITU, intensive therapy unit; CPS, Child-Pugh score; MELD, model for end stage liver disease; UKELD, United Kingdom end 
stage liver disease 
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Table 5. Survival analysis: factors predictive of mortality excluding early deaths*. 
 
 Univariate Cox regression  Multivariate  Cox regression  
Multivariate Cox regression 
Competing risks: 
Death or LT 
 HR 95% CI P HR 95% CI P HR 95% CI P 
MELD score 1.063 1.037-1.089 <0.001 1.068 1.040-1.097 <0.001 1.06 
1.02-  
1.11 
0.002 
History of bacterial 
infection 
1.784 1.277-2.492 0.001 1.613 1.144-2.274 0.006 1.67 1.06-2.62 0.03 
ITU stay 1.013 0.533-1.926 0.969       
UKELD score 1.066 1.040-1.092 <0.001       
CPS B and C 1.775 1.115-2.826 0.016       
In-hospital stay >10 
days 
1.755 1.251-2.463 0.001    
   
Admission for 
decompensated 
1.355 0.932-1.969 0.112    
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liver disease or infection 
Age 1.022 1.009-1.036 0.001 1.029 1.015-1.044 <0.001 1.03 1.02-1.05 <0.001 
≥2 admissions 1.491 1.071-2.075 0.018       
 
*deaths that occurred in less than 30 days from admission 
Abbreviations: ITU, intensive therapy unit; CPS, Child-Pugh score; MELD, model for end stage liver disease; UKELD, United Kingdom end 
stage liver disease 
  
Page 30 of 42
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901
American Journal of Gastroenterology
For Peer Review
 
Figure 1. Kaplan Meier survival curves in patients with and without diagnosis of infection. 
 
 
Figure 2. Kaplan Meier survival curves in patients with MELD<15 and infection, MELD ≥15 and no infection, MELD <15 and infection, MELD 
≥15 and no infection 
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Web appendix. 
Table 1. Propensity score (PS) matching for all patients 
 
 Propensity score matched 
 Non Infected 
 (n=165) 
Infected 
(n=165) 
P-value 
Age (years) 52.7 (12.4) 53.8 (12.7) 0.31
*
 
Male gender 103 (62.4) 99 (60.0) 0.73
§
 
HCC (yes) 15 (9.1) 10 (6.1) 0.42
§
 
OLT (yes) 18 (10.9) 18 (10.9) 1.00
§
 
MELD 18.3 (6.7) 18.7 (7.0) 0.02
*
 
Reason of admission   1.00
§
 
Acute decompensation or 
infection 
138 (83.6) 139 (84.2)  
Other reasons 27 (16.4) 26 (15.8)  
ITU stay (yes) 12 (7.3) 28 (17.0) 0.02
§
 
UKELD score 56.4 (6.3) 57.8 (7.0) 0.01
*
 
CPS    0.11
#
 
A 20 (13.8) 14 (9.7)  
B 75 (51.7) 64 (44.1)  
C 50 (34.5) 67 (46.2)  
In-hospital stay >10 days 66 (40.0) 116 (70.3) <0.001
§
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Admissions (≥2) 37 (22.4) 74 (44.8) <0.001
§
 
Values expressed as mean (SD) and number (per cent) where appropriate. 
*
Wilcoxon signed-rank test. 
§
McNemar test. 
#
 McNemar-Bowker test. 
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Table 2. Univariate and multivariate analysis of factors associated with infection 
 
 Univariate analysis Multivariate analysis 
 OR 95% CI P OR 95% CI P 
Age 1.999 0.988-1.011 0.922    
Sex 0.879 0.644-1.200 0.418    
Etiology 0.953 0.797-1.139 0.596    
Number of admissions 
(1 vs. ≥2) 
1.829 1.347-2.485 <0.001 2.000 1.454-2.751 <0.001 
ITU stay 1.872 1.247-2.810 0.002 1.908 1.244-2.926 0.003 
CPS score non-A 1.985 1.200-3.284 0.008 - - NS 
MELD score 1.032 1.011-1.053 0.003 1.026 1.004-1.049 0.020 
UKELD score 1.044 1.023-1.066 <0.001    
 
Abbreviations: ITU, intensive therapy unit; CPS, Child-Pugh score; MELD, model for 
end stage liver disease; UKELD, United Kingdom end stage liver disease 
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Table 3. Survival analysis: factors predictive of short-term mortality at 30 days 
 
Factor Univariate Cox regression analysis Multivariate Cox regression analysis 
 HR 95% CI P HR 95% CI P 
MELD score 1.130 1.094-1.167 0.075 1.110 1.071-1.150 <0.001 
Presence of bacterial infection 4.404 2.335-8.305 <0.001 2.846 1.474-5.498 0.002 
ITU stay 5.456 2.952-10.084 <0.001 2.579 1.343-4.954 0.004 
UKELD score 1.138 1.095-1.183 <0.001    
CPS B and C 27.885 0.973-799.21 0.052    
In-hospital stay >10 days 1.925 1.032-3.590 0.040    
Admission for decompensated 
liver disease or infection 
2.988 1.263-7.068 0.013    
Age 1.004 0.980-1.029 0.743    
≥2 admissions 2.552 1.142-5.706 0.022 2.272 0.985-5.244 0.054 
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Table 4. Multivariate Cox regression analysis of variables associated with death 
by classifying the infection event as a categorical time-dependent covariate to 
account for immortal time bias. 
 HR 95% CI P 
MELD score 1.10 1.07-1.12 <0.001 
Age 1.03 1.02-1.05 <0.001 
ITU stay 1.89 1.22-2.92 0.004 
History of bacterial infection 
(yes) 
2.41 1.80-3.24 <0.001 
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Table 5. Multivariate Competing risk Cox regression analysis of variables associated 
with death, in propensity score-matched patients who survived an episode of the 
infection.  
 HR 95% CI P 
MELD score 1.06 1.02-1.11 0.002 
Age 1.03 1.02-1.05 <0.001 
History of bacterial infection 
(yes) 
1.67 1.06-2.62 0.03 
 
Abbreviations: MELD, model for end stage liver disease. 
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Table 6. Multivariate Cox regression analysis of variables associated with death 
in patients who survived an episode of infection. The infection event was 
classified as a categorical time-dependent covariate to account for immortal time 
bias. 
 HR 95% CI P 
MELD score 1.06 1.03-1.09 <0.001 
Age 1.03 1.02-1.05 <0.001 
History of bacterial infection 
(yes) 
2.07 1.47-2.90 <0.001 
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